Claudin 18.2: a promising actionable target in biliary tract cancers.

ESMO Open · 2025 · PMC12018027 · PMID 40215597

Europe PMC DOI

hedged sentence

0.1060

closest p · 2.1× alpha

0.1060

boldest claim

The sentences

did not reach statistical significanceP = 0.106not close (p > 0.1)

Likewise, CLDN18 positivity was higher in large duct iCCAs than in small duct iCCAs, but this difference did not reach statistical significance [6.7% (2/30) versus 0.9% (1/117), P = 0.106].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.